Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

Authors

  • Milton A Ruiz Bone Marrow Transplantation and Cell Therapy Unit, Associação Portuguesa de Beneficência de São José do Rio Preto, São José do Rio Preto, Brazil
  • Maria Carolina Oliveira Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo
  • Daniela Moraes Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
  • Juliana Dias Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
  • Lilian Piron-Ruiz Bone Marrow Transplantation and Cell Therapy Unit, Associação Portuguesa de Beneficência de São José do Rio Preto, São José do Rio Preto, Brazil
  • Andreza Ribeiro Bone Marrow Transplantation Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil
  • Morgani Rodrigues Bone Marrow Transplantation Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil
  • Nelson Hamerschlak

DOI:

https://doi.org/10.46765/2675-374X.2023v4n1p182

Keywords:

autoimmune disease, hematopoietic stem cell transplantation, multiple sclerosis, systemic sclerosis, Crohn's disease

Abstract

Autoimmune diseases are an important field for the development of hematopoietic stem cell transplantation (HSCT). The Brazilian Society for Cellular Therapy and Bone Marrow Transplantation (Sociedade Brasileira de Terapia Celular e Transplante de Medula Óssea, SBTMO) organized consensus meetings for the Autoimmune Diseases Group, to review the available literature on HSCT for autoimmune diseases, aiming to gather data that support the procedure for these patients. Three autoimmune diseases for which there are evidence-based indications for HSCT are multiple sclerosis, systemic sclerosis and Crohn’s disease. The professional stem cell transplant societies in North America (ASTCT), Europe (EBMT) and Brazil (SBTMO) currently consider HSCT as a therapeutic modality for these three autoimmune diseases. The data are here updated.

Author Biography

Maria Carolina Oliveira, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo

Second affiliation:

Center for Cell-based Therapy, Regional Blood Center, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

Downloads

Published

02/22/2023

How to Cite

Ruiz, M. A., Oliveira, M. C., Moraes, D., Dias, J., Piron-Ruiz, L., Ribeiro, A., Rodrigues, M., & Hamerschlak, N. (2023). Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 4(1), 182. https://doi.org/10.46765/2675-374X.2023v4n1p182

Issue

Vol. 4 No. 1 (2023): CONSENSUS UPDATE

Section

Original article

License

Copyright (c) 2023 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

License and Copyright Policy

The Journal of Bone Marrow Transplantation and Cellular Therapy (JBMTCT) adopts an open access policy, ensuring that all published articles are freely available to the public without restrictions.

  1. License

    • All articles published in JBMTCT are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
    • This license permits anyone to:
      • Share: Copy and redistribute the material in any medium or format.
      • Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
    • The only requirement is that appropriate credit is given to the original authors and source, a link to the license is provided, and any changes made are indicated.

    More information about the license can be found here: Creative Commons Attribution 4.0 International License.

  2. Authors’ Rights

    • Authors retain the copyright to their work.
    • Authors grant JBMTCT the right to publish the work and make it openly accessible online.
    • Authors are free to:
      • Distribute the published version of their article (e.g., post it on personal websites or institutional repositories).
      • Use the article in future works, presentations, or derivative publications, as long as the original publication in JBMTCT is properly acknowledged.

  3. No Embargo

    • There is no embargo period; articles are made freely available immediately upon publication.

  4. Ethical Use

    • Users of JBMTCT articles must ensure proper citation of the authors and the journal.
    • Articles must not be used in ways that violate ethical or legal standards.

  5. Disclaimer

    • While JBMTCT aims to ensure the accuracy and reliability of published content, the journal and its editors are not responsible for the consequences of its use.

For any questions regarding our licensing terms, please contact us at: journalbmtct@sbtmo.org.br 

JBMTCT is committed to the principles of open access to advance knowledge and scientific collaboration.

 

Most read articles by the same author(s)

1 2 3 > >> 

Similar Articles

You may also start an advanced similarity search for this article.